Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the Young TAVR Registry.

Navarese EP, Andreotti F, Kołodziejczak M, Wanha W, Lauten A, Veulemans V, Frediani L, Kubica J, de Cillis E, Wojakowski W, Ochala A, Zeus T, Bortone A, Buffon A, Jung C, Pestrichella V, Gurbel PA.

Mayo Clin Proc. 2019 Feb 26. pii: S0025-6196(19)30044-8. doi: 10.1016/j.mayocp.2019.01.008. [Epub ahead of print]

PMID:
30824280
2.

"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke.

Bliden KP, Raviv G, Tantry US, Chaudhary R, Cochran JW, Navarese EP, Brannan T, Vyas A, Gurbel PA.

J Thromb Thrombolysis. 2019 Feb;47(2):192-199. doi: 10.1007/s11239-019-01813-0.

PMID:
30673942
3.

Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease.

Koh JS, Park Y, Ahn JH, Kang MG, Kim KH, Bae JS, Park HW, Jang JY, Park JR, Hwang SJ, Kwak CH, Hwang JY, Tantry US, Gurbel PA, Jeong YH.

Thromb Haemost. 2019 Feb;119(2):264-273. doi: 10.1055/s-0038-1676795. Epub 2019 Jan 4.

PMID:
30609441
4.

Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?

Mahla E, Tantry US, Prüller F, Gurbel PA.

Circulation. 2018 Nov 6;138(19):2145-2159. doi: 10.1161/CIRCULATIONAHA.118.035160.

PMID:
30474416
5.

Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients.

Åstrand M, Amilon C, Röshammar D, Himmelmann A, Angiolillo DJ, Storey RF, Gurbel PA, Bonaca MP, Hamrén B.

Br J Clin Pharmacol. 2019 Feb;85(2):413-421. doi: 10.1111/bcp.13812. Epub 2018 Dec 18.

6.

Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.

Brener SJ, Kirtane AJ, Rinaldi MJ, Stuckey TD, Witzenbichler B, Weisz G, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Gurbel PA, Brodie BR, Mehran R, McAndrew T, Stone GW.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.

PMID:
30354629
7.

Antithrombotic Strategies and Device Thrombosis.

Gurbel PA, Shah P, Desai S, Tantry US.

Cardiol Clin. 2018 Nov;36(4):541-550. doi: 10.1016/j.ccl.2018.06.008. Epub 2018 Sep 15. Review.

PMID:
30297071
8.

Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review.

Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):47-54. doi: 10.1093/ehjcvp/pvy038.

PMID:
30247574
9.

Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).

Hinohara TT, Roe MT, White HD, Fox KAA, Bhatt DL, Hamm C, Gurbel PA, Aylward PE, Wiviott SD, Huber K, Neely ML, Ohman EM.

Am J Cardiol. 2018 Oct 15;122(8):1322-1329. doi: 10.1016/j.amjcard.2018.06.052. Epub 2018 Jul 19.

PMID:
30135019
10.

Cangrelor for the treatment of patients with Arterial Thrombosis.

Tantry U, Chaudhary R, Kubica J, Bliden K, Gurbel PA.

Expert Opin Pharmacother. 2018 Aug;19(12):1389-1398. doi: 10.1080/14656566.2018.1506767. Epub 2018 Aug 13. Review.

PMID:
30102083
11.

Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes.

Tantry US, Navarese EP, Bliden KP, Gurbel PA.

Kardiol Pol. 2018;76(9):1312-1319. doi: 10.5603/KP.a2018.0159. Epub 2018 Aug 9. Review.

12.

Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.

Navarese EP, Wernly B, Lichtenauer M, Petrescu AM, Kołodziejczak M, Lauten A, Frediani L, Veulemanns V, Wanha W, Wojakowski W, Lesiak M, Ferrante G, Zeus T, Tantry U, Bliden K, Buffon A, Contegiacomo G, Jung C, Kubica J, Pestrichella V, Gurbel PA.

Int J Cardiol. 2018 Oct 15;269:292-297. doi: 10.1016/j.ijcard.2018.07.009. Epub 2018 Jul 3.

PMID:
30045826
13.

Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.

Alexopoulos D, Xenogiannis I, Vlachakis P, Tantry U, Gurbel PA.

Thromb Haemost. 2018 Jul;118(7):1131-1140. doi: 10.1055/s-0038-1649484. Epub 2018 Jun 4.

PMID:
29864784
14.

Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention.

Navarese EP, Kołodziejczak M, Petrescu A, Wernly B, Lichtenauer M, Lauten A, Buffon A, Wanha W, Pestrichella V, Sardella G, Contegiacomo G, Tantry U, Bliden K, Kubica J, Gurbel PA.

Expert Rev Cardiovasc Ther. 2018 Jun;16(6):419-429. doi: 10.1080/14779072.2018.1474099. Epub 2018 May 23. Review.

PMID:
29737886
15.

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA.

JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525. Review. Erratum in: JAMA. 2018 Oct 2;320(13):1387.

16.

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR; ICPC Investigators.

Am Heart J. 2018 Apr;198:152-159. doi: 10.1016/j.ahj.2017.12.010. Epub 2017 Dec 17. Review.

PMID:
29653637
17.

Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.

Mahla E, Metzler H, Bornemann-Cimenti H, Prueller F, Raggam RB, Pregartner G, Berghold A, Baumann A, Goeroeg C, Gurbel PA.

Thromb Haemost. 2018 May;118(5):864-872. doi: 10.1055/s-0038-1641153. Epub 2018 Apr 6.

PMID:
29625498
18.

Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.

Rana R, Huang T, Koukos G, Fletcher EK, Turner SE, Shearer A, Gurbel PA, Rade JJ, Kimmelstiel CD, Bliden KP, Covic L, Kuliopulos A.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1368-1380. doi: 10.1161/ATVBAHA.118.310967. Epub 2018 Apr 5.

PMID:
29622563
19.

Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments.

Tantry US, Navarese EP, Myat A, Chaudhary R, Gurbel PA.

Expert Opin Pharmacother. 2018 May;19(7):653-665. doi: 10.1080/14656566.2018.1457649. Epub 2018 Apr 11. Review.

PMID:
29611444
20.

Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction.

Navarese EP, Wernly B, Lichtenauer M, Pepe M, Wanha W, Ferrante G, Frediani L, Veulemans V, Zeus T, Westenfeld R, Jung C, Gurbel PA.

J Thorac Dis. 2018 Jan;10(1):17-20. doi: 10.21037/jtd.2017.11.125. No abstract available.

21.

Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.

Gurbel PA, Tantry US, D'Andrea D, Chung T, Alexander JH, Bliden KP, Wright SD, Tricoci P.

J Thromb Thrombolysis. 2018 May;45(4):469-476. doi: 10.1007/s11239-018-1644-z.

22.

Rivaroxaban in Stable Cardiovascular Disease.

Jeong YH, Bae JS, Gurbel PA.

N Engl J Med. 2018 Jan 25;378(4):396. doi: 10.1056/NEJMc1714934. No abstract available.

PMID:
29372978
23.

Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?

Bae JS, Ahn JH, Tantry US, Gurbel PA, Jeong YH.

Curr Vasc Pharmacol. 2018;16(5):459-476. doi: 10.2174/1570161116666180117103238.

PMID:
29345591
24.

Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome.

Tantry US, Navarese EP, Myat A, Gurbel PA.

Prog Cardiovasc Dis. 2018 Jan - Feb;60(4-5):460-470. doi: 10.1016/j.pcad.2018.01.003. Epub 2018 Jan 12. Review.

PMID:
29339168
25.

Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view.

Pepine CJ, Gurbel PA.

Clin Cardiol. 2017 Dec;40(12):1352-1356. doi: 10.1002/clc.22814. Epub 2017 Dec 16. Review.

26.

Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium.

Gurbel PA, Bliden KP, Zhu J, Troullos E, Centofanti R, Jarvis S, Venkataraman P, Tantry US.

J Thromb Thrombolysis. 2018 Jan;45(1):18-26. doi: 10.1007/s11239-017-1593-y.

PMID:
29198079
27.

Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score.

Bliden KP, Chaudhary R, Navarese EP, Sharma T, Kaza H, Tantry US, Gurbel PA.

Atherosclerosis. 2018 Jan;268:55-62. doi: 10.1016/j.atherosclerosis.2017.11.018. Epub 2017 Nov 20.

PMID:
29175655
28.

Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern?

Venkataraman G, Bliden KP, Tantry US, Gurbel PA.

Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27402. [Epub ahead of print]

PMID:
29130638
29.

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.

Angiolillo DJ, Rollini F, Storey RF, Bhatt DL, James S, Schneider DJ, Sibbing D, So DYF, Trenk D, Alexopoulos D, Gurbel PA, Hochholzer W, De Luca L, Bonello L, Aradi D, Cuisset T, Tantry US, Wang TY, Valgimigli M, Waksman R, Mehran R, Montalescot G, Franchi F, Price MJ.

Circulation. 2017 Nov 14;136(20):1955-1975. doi: 10.1161/CIRCULATIONAHA.117.031164. Epub 2017 Oct 30. Review.

PMID:
29084738
30.

Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?

Gurbel PA, Navarese EP, Tantry US.

J Am Coll Cardiol. 2017 Sep 19;70(12):1463-1466. doi: 10.1016/j.jacc.2017.07.779. No abstract available.

31.

More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor.

Tantry US, Jeong YH, Gurbel PA.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1659-1661. doi: 10.1016/j.jcin.2017.06.014. No abstract available.

32.

Low-density lipoprotein 4: a novel predictor of coronary artery disease severity.

Chaudhary R, Mathew D, Bliden K, Tantry US, Sharma T, Gesheff MG, Franzese CJ, Pandya S, Toth PP, Gurbel PA.

Curr Med Res Opin. 2017 Nov;33(11):1979-1984. doi: 10.1080/03007995.2017.1365052. Epub 2017 Sep 1.

PMID:
28787217
33.

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.

Stuckey TD, Kirtane AJ, Brodie BR, Witzenbichler B, Litherland C, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Gurbel PA, Mehran R, Généreux P, Ben-Yehuda O, Simonton CA, Stone GW; ADAPT-DES Investigators.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1607-1617. doi: 10.1016/j.jcin.2017.05.059. Epub 2017 Aug 2.

34.

Central aortic pulse pressure, thrombogenicity and cardiovascular risk.

Chen G, Bliden KP, Chaudhary R, Liu F, Kaza H, Navarese EP, Tantry US, Gurbel PA.

J Thromb Thrombolysis. 2017 Aug;44(2):223-233. doi: 10.1007/s11239-017-1524-y.

PMID:
28695310
35.

Bleeding and thrombosis associated with ventricular assist device therapy.

Shah P, Tantry US, Bliden KP, Gurbel PA.

J Heart Lung Transplant. 2017 Nov;36(11):1164-1173. doi: 10.1016/j.healun.2017.05.008. Epub 2017 May 11. Review.

PMID:
28579115
36.

Ticagrelor versus Clopidogrel in Peripheral Artery Disease.

Ahn J-H, Gurbel PA, Jeong Y-H.

N Engl J Med. 2017 Apr 13;376(15):1487-8. doi: 10.1056/NEJMc1701197. No abstract available.

PMID:
28402762
37.

ANTARCTIC: platelet function testing to adjust therapy.

Gurbel PA, Price MJ, Dahlen JR, Tantry US.

Lancet. 2017 Mar 25;389(10075):1193. doi: 10.1016/S0140-6736(17)30780-8. No abstract available.

PMID:
28353442
38.

GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.

Gurbel PA, Tantry US.

Lancet. 2017 May 6;389(10081):1773-1775. doi: 10.1016/S0140-6736(17)30760-2. Epub 2017 Mar 18. No abstract available.

PMID:
28325639
39.

Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.

Bliden KP, Chaudhary R, Mohammed N, Muresan AA, Lopez-Espina CG, Cohen E, Raviv G, Doubleday M, Zaman F, Mathew B, Tantry US, Gurbel PA.

J Thromb Thrombolysis. 2017 May;43(4):437-445. doi: 10.1007/s11239-017-1477-1.

PMID:
28247290
40.

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

Winter MP, Grove EL, De Caterina R, Gorog DA, Ahrens I, Geisler T, Gurbel PA, Tantry U, Navarese EP, Siller-Matula JM.

Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):221-234. doi: 10.1093/ehjcvp/pvw044. Review.

PMID:
28204303
41.

Rapid Desensitization of the Patients With Aspirin Hypersensitivity and Coronary Artery Disease.

Tantry US, Gurbel PA.

Circ Cardiovasc Interv. 2017 Feb;10(2). pii: e004881. doi: 10.1161/CIRCINTERVENTIONS.117.004881. No abstract available.

PMID:
28193681
42.

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis.

Navarese EP, Gurbel PA, Andreotti F, Kołodziejczak MM, Palmer SC, Dias S, Buffon A, Kubica J, Kowalewski M, Jadczyk T, Laskiewicz M, Jędrzejek M, Brockmeyer M, Airoldi F, Ruospo M, De Servi S, Wojakowski W, O' Connor C, Strippoli GF.

PLoS One. 2017 Feb 2;12(2):e0168726. doi: 10.1371/journal.pone.0168726. eCollection 2017. Review.

43.

Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.

Park Y, Tantry US, Koh JS, Ahn JH, Kang MG, Kim KH, Jang JY, Park HW, Park JR, Hwang SJ, Park KS, Kwak CH, Hwang JY, Gurbel PA, Jeong YH.

Thromb Haemost. 2017 May 3;117(5):911-922. doi: 10.1160/TH16-10-0744. Epub 2017 Feb 2.

PMID:
28150852
44.

HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm.

Gurbel PA, deFilippi CR, Bliden KP, Tantry US.

Eur Heart J. 2017 Jun 1;38(21):1687-1689. doi: 10.1093/eurheartj/ehw630. No abstract available.

PMID:
28087604
45.

Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease.

Sharma T, Bliden K, Chaudhary R, Tantry U, Gurbel PA.

Expert Opin Pharmacother. 2017 Jan;18(1):123-131. doi: 10.1080/14656566.2016.1269747. Review.

PMID:
27937054
46.

Cigarette Smoking, Clopidogrel Responsiveness, and Hemoglobin Level.

Gurbel PA, Bliden KP, Baker BA, Dahlen J, Tantry US.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2364. doi: 10.1016/j.jcin.2016.09.026. No abstract available.

47.

The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.

Jakubowski JA, Erlinge D, Alexopoulos D, Small DS, Winters KJ, Gurbel PA, Angiolillo DJ.

Am J Cardiovasc Drugs. 2017 Apr;17(2):109-121. doi: 10.1007/s40256-016-0202-3. Review.

PMID:
27854064
48.

Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications.

Kim JH, Shah P, Tantry US, Gurbel PA.

Curr Heart Fail Rep. 2016 Dec;13(6):319-328. Review.

PMID:
27815681
49.

Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

Cornel JH, Ohman EM, Neely B, Jakubowski JA, Bhatt DL, White HD, Ardissino D, Fox KA, Prabhakaran D, Armstrong PW, Erlinge D, Tantry US, Gurbel PA, Roe MT.

J Am Heart Assoc. 2016 Nov 4;5(11). pii: e003977.

50.

First report of the point-of-care TEG: A technical validation study of the TEG-6S system.

Gurbel PA, Bliden KP, Tantry US, Monroe AL, Muresan AA, Brunner NE, Lopez-Espina CG, Delmenico PR, Cohen E, Raviv G, Haugen DL, Ereth MH.

Platelets. 2016 Nov;27(7):642-649. Epub 2016 Apr 11.

PMID:
27809712

Supplemental Content

Loading ...
Support Center